(Q39561175)

13 September 2017

The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma (English)

1 reference

13 September 2017

10

Liangfu Zhou

1 reference

13 September 2017

9

Ying Mao

1 reference

13 September 2017

Wei Hua

1

1 reference

13 September 2017

Yu Yao

2

1 reference

13 September 2017

Yiwei Chu

3

1 reference

13 September 2017

Ping Zhong

4

1 reference

13 September 2017

Xiaofang Sheng

5

1 reference

13 September 2017

Baoguo Xiao

6

1 reference

13 September 2017

Jingsong Wu

7

1 reference

13 September 2017

Bojie Yang

8

1 reference

13 September 2017

11 April 2011

1 reference

Journal of Neuro-Oncology

13 September 2017

1 reference

13 September 2017

105

1 reference

13 September 2017

2

1 reference

13 September 2017

149-157

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-011-0572-y

13 September 2017

0 references

cites work

Treatment of astrocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Transcriptional expression of survivin and its splice variants in brain tumors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Expression of the tumor-rejection antigen SART1 in brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Neoplastic stem cells: a novel therapeutic target in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Updates in cancer research: insights from the AACR 100th Annual Meeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Glioma cell populations grouped by different cell type markers drive brain tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Immunobiological characterization of cancer stem cells isolated from glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Limbal epithelial stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0572-Y

Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain

21 January 2018

1 reference

12 December 2020

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

1 reference

12 December 2020

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

12 December 2020

Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory

1 reference

12 December 2020

Dendritic cell-based active specific immunotherapy for malignant glioma

1 reference

12 December 2020

The immunobiology of malignant gliomas.

1 reference

12 December 2020

10.1007/S11060-011-0572-Y

Identifiers

DOI

1 reference

13 September 2017

1 reference